Patent ID: 6869939

Claim:
A water dilutable clear liquid formulation comprising amiodarone and a sulfoalkyl ether cyclodextrin (SAE-CD), wherein the molar ratio of SAE-CD to amiodarone is greater than or equal to about 1.1±0.01, and the liquid formulation is dilutable with water at ambient temperature without significant precipitation of amiodarone and without the need of surfactant, organic solvent, soap or detergent, and wherein the SAE-CD is a compound or mixture of compounds of the Formula 1 wherein: n is 5, or 6; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are each, independently, —O— or a —O—(C 2 -C 6 alkylene)-SO 3 − group, wherein at least one of R 1 and R 2 is independently a —O—(C 2 -C 6 alkylene)-SO 3 − group; and S 1 , S 2 , S 3 , S 4 , S 5 , S 6 , S 7 , S 8 , and S 9 are each, independently, a pharmaceutically acceptable cation.